TAVI non-inferior to SAVR in moderate risk patients with severe symptomatic aortic stenosis
By Dr. Aswin Babu Since the first transcatheter aortic valve implantation (TAVI) in 2002, developments in valve technology, procedural techniques and operator experience have led…
View More TAVI non-inferior to SAVR in moderate risk patients with severe symptomatic aortic stenosis
Predicting outcome after cardiac resynchronisation therapy defibrillator implantation: the CRT-D Futility score
By Dr Jonathan Shurlock Dr Baptiste Maille and co-authors have revisited the debate regarding the use of cardiac resynchronisation therapy – defibrillator (CRT-D) and –…
View More Predicting outcome after cardiac resynchronisation therapy defibrillator implantation: the CRT-D Futility score
Importance of genetic testing in unexplained cardiac arrest
By Dr Jonathan Shurlock A Canadian group led by Steffany Grondin at the Montreal Heart Institute have explored the role of genetic testing for patients…
View More Importance of genetic testing in unexplained cardiac arrest
Joint British Societies’ guideline on management of cardiac arrest in the cardiac catheter laboratory
By Dr Jonathan Shurlock Cardiac arrest in the cardiac catheter laboratory, particularly during complex procedures, can be difficult to manage in a safe and efficient…
View More Joint British Societies’ guideline on management of cardiac arrest in the cardiac catheter laboratory
Machine learning predicts factors associated with device infection during secondary procedures
By Dr Aswin Babu Tarakji et al. (2022) recently published post hoc analysis of 2,803 control patients from the WRAP-IT trial who underwent secondary device…
View More Machine learning predicts factors associated with device infection during secondary procedures
Atrial fibrillation and silent infarcts, is anticoagulation enough?
By Dr Jonathan Shurlock The use of anticoagulation to reduce the risk of stroke in patients with AF is widespread, often protocol driven, and guided…
View More Atrial fibrillation and silent infarcts, is anticoagulation enough?
Post-COVID vaccine myocarditis: UK reporting rates and recent statistics
By Dr Timothy Swinn The Medicines & Healthcare products Regulation Agency (MHRA) in the UK uses the voluntary “Yellow Card” system for reporting suspected adverse…
View More Post-COVID vaccine myocarditis: UK reporting rates and recent statistics
Consistent evidence for the role of social isolation in cardiovascular risk
By Dr Jonathan Shurlock Multiple population level studies have demonstrated the association between objective or perceived social isolation and cardiovascular risk. Golaszewski et al. have…
View More Consistent evidence for the role of social isolation in cardiovascular risk
Can ‘low-risk’ patients with aortic stenosis be stratified?
By Dr Jonathan Shurlock Patients with aortic stenosis (AS) have received increasing attention with recent work raising concerns regarding the assumption of being low risk…
View More Can ‘low-risk’ patients with aortic stenosis be stratified?
A summary of… Heart failure multidisciplinary meetings: joint British Society consensus guidelines for structure and function
By Dr Megha Agarwal Multi-disciplinary meetings form an important part of the clinical pathway for complex heart failure patients. The above titled document aims to…
View More A summary of… Heart failure multidisciplinary meetings: joint British Society consensus guidelines for structure and function